4% tetrasodium EDTA decreases central venous access device complications in ICU

ORLANDO — ICU patients with a central venous access device had a smaller incidence rate of device-related complications with 4% tetrasodium ethylenediaminetetraacetic acid vs. control locking fluid, according to results presented here.In addition to being presented at the American Thoracic Society International Conference, these data were simultaneously published in JAMA.